Last reviewed · How we verify
Intravenous Neostigmine and Glycopyrrolate
Intravenous Neostigmine and Glycopyrrolate is a Small molecule drug developed by James J. Peters Veterans Affairs Medical Center. It is currently in Phase 1 development.
At a glance
| Generic name | Intravenous Neostigmine and Glycopyrrolate |
|---|---|
| Sponsor | James J. Peters Veterans Affairs Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetics of Neostigmine and Glycopyrrolate (EARLY_PHASE1)
- Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery (PHASE4)
- Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169) (PHASE4)
- Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block (PHASE4)
- Sugammadex To IMprove Bowel Function (PHASE4)
- Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients (NA)
- Neostigmine and Glycopyrrolate by Iontophoresis (PHASE3)
- Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous Neostigmine and Glycopyrrolate CI brief — competitive landscape report
- Intravenous Neostigmine and Glycopyrrolate updates RSS · CI watch RSS
- James J. Peters Veterans Affairs Medical Center portfolio CI
Frequently asked questions about Intravenous Neostigmine and Glycopyrrolate
What is Intravenous Neostigmine and Glycopyrrolate?
Intravenous Neostigmine and Glycopyrrolate is a Small molecule drug developed by James J. Peters Veterans Affairs Medical Center.
Who makes Intravenous Neostigmine and Glycopyrrolate?
Intravenous Neostigmine and Glycopyrrolate is developed by James J. Peters Veterans Affairs Medical Center (see full James J. Peters Veterans Affairs Medical Center pipeline at /company/james-j-peters-veterans-affairs-medical-center).
What development phase is Intravenous Neostigmine and Glycopyrrolate in?
Intravenous Neostigmine and Glycopyrrolate is in Phase 1.